Search Results 991-1000 of 15961 for Residual

1. Carpal Tunnel Syndrome Clinical Trials - Mayo Clinic Research

   ... residual scar tenderness, and post-operative complications. A Non-Invasive Technique for Measuring Tendon Elasticity with Surface Wave Speed for the Patient ...

2. A Study of Continuous Positive Airway Pressure Treatment for Obstructive Sleep Apnea to Prevent Cardiovascular Disease - Mayo Clinic

   Minor disabling stroke with minimal residual neurological disability and modified Rankin Score of '0 = no symptoms' or '1 = No significant disability ...

3. Barrett's Esophagus Clinical Trials

   Cryo Balloon for Residual Barrett's Esophagus No Locations. To assess the response of persistent Barrett's Esophagus and/or dysplasia to focal cyro ablation ...

4. Health & Wellness - Page 686 of 781 - Mayo Clinic News Network

   Less Invasive Surgery Finds Residual Breast Cancer in Lymph Nodes After Chemotherapy. Dana Sparks. October 3, 2013. A Proud Past … an Exciting Future of Hope ...

5. Spinal Cord Injury Clinical Trials - Mayo Clinic Research

   The purpose of this study is to analyze this correlation to better understand the relationship between spasticity as a biomarker of residual corticospinal ...

6. A Study to Evaluate the Safety and Effectiveness of the GORE® TAG® Thoracic Branch Endoprosthesis for Treating Lesions of the Aortic Arch and Chest Aorta - Mayo Clinic

   Residual aortic dissection following surgical repair of Type A aortic dissection requiring treatment. TBE implant must be at least 14 days after the ...

7. Thymic hyperplasia in severe Graves' hyperthyroidism: A case from the endocrine teaching clinics

   A 58-year-old woman presented to the Endocrine Clinics at Mayo Clinic in Rochester, Minnesota, with symptoms of chest pressure, palpitations, insomnia and ...

8. A Phase I Study of MSB2311 in Advanced Solid Tumors - Mayo Clinic

   03, with exception of the residual hair loss;; Received a biologic G-CSF, GM-CSF or erythropoietin within 14 days prior to the first dose of study drug ...

9. XmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic Leukemia - Mayo Clinic

   Subjects with measurable residual disease by flow cytometry, molecular testing or cytogenetics will be eligible for the trial. 4. CD38 expression ≥ 20% by ...

10. A Study to Evaluate Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment for Stage I-IIIA Malignant Pleural Mesothelioma - Mayo Clinic

    Bulky residual disease in the major fissure preventing pleural IMRT. Patients who have undergone extrapleural pneumonectomy. Patients with active infection ...